Download Medical Notes on 2019 R&D Achievements New product launches, clinical trial activity, and investments

2019 R&D Achievements New product launches, clinical trial activity, and investments Medical Notes

About This Presentation

Description:This report titled, “Innovation in Diabetes Care Technology” is by the IQVIA Institute and assesses the current status in the R&D of medicines, especially coronavirus COVID-19 pandemic outbreak. The report provides an analysis of the number of initiated clinical trials and insight into the success rate of products after development. The current state of innovation is explored by examining the record numbers of new active substances (NAS) launched in 2019, analyzing their features and development path, as well as the important contributions of both NAS and non-NAS therapies. The levels of life science venture capital activity and large pharma R&D spend grew. This report also details the expanding pipeline of therapies still under development, examines trends among therapy areas, and analyzes the growing number of Next- Generation Biotherapeutic products, which include cell, gene, and nuc

Tags:COVID-19, pandemic, clinical trials, new product development, pharma R and D, pharma pharmaceutical

Published on: Jul 20, 2020 | Views : 1880 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

About : I am a passionate medical marketing professional with hands on experience in healthcare digital marketing.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : India
Website :

Distribution Healthcare Marketing

The Impact of COVID-19 on Cancer Treatment in Japan

How to Win Patients with a Consumer-Grade Contact Center Experience

Upliftment of OTC Medicines Towards Innovative Marketing Strategies

Life after cancer

Evaluate Vantage Report on impact of COVID-19 Biopharma and Medtech

Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2019

2020 US and global life sciences outlook

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

A Blueprint for Improving the Security of the USA Pharmaceutical Supply Chain

HEALTH A TO Z